CXCR3 and COVID-19: In addition to a transitory increase in tissue-homing CXCR3 + plasmablasts and extrafollicular memory B cells, most COVID-19 patients showed persistent activation of CD4 + and CD8 + T cells along with transient or long-lasting changes of key innate immune cells.